4.6 Article

Pan-Cancer Bioinformatics Analysis of Gene UBE2C

Journal

FRONTIERS IN GENETICS
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fgene.2022.893358

Keywords

gene Expression; pan-cancer; GSE data; prognostic analysis; TCGA; immune infiltration

Funding

  1. National Natural Science Foundation of China [62002189, 62002187, 62102200]
  2. Natural Science Foundation of Shandong Province, China [ZR2020QF038, ZR2021MH104, ZR2020MH208]
  3. Young Taishan Scholars Program, Shandong, China [tsqn201909178]

Ask authors/readers for more resources

This paper focuses on studying the differential mechanism of gene expression of UBE2C in various tumors and its correlation with prognosis, clinical features, immunity, methylation, and other characteristics, based on public databases.
Ubiquitin-Conjugating Enzyme E2 C (UBE2C) is a gene that encodes protein. Disorders associated with UBE2C include methotrexate-related lymphatic hyperplasia and complement component 7 deficiency. The encoded protein is necessary for the destruction of mitotic cell cyclins and cell cycle progression, and may be involved in cancer progression. In this paper, on the basis of public databases, we study the expression differential mechanism of gene expression of UBE2C in various tumors and the performance of prognosis, clinical features, immunity, methylation, etc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available